Başkurt K., Uyar G. C., Yeşilbaş E., Büyükşimşek M., Sertesen Çamöz E., Yılmaz E., ...Daha Fazla
CURRENT ONCOLOGY, cilt.33, sa.11, ss.1-12, 2026 (SCI-Expanded, Scopus)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
33
Sayı:
11
-
Basım Tarihi:
2026
-
Doi Numarası:
10.3390/curroncol33110712
-
Dergi Adı:
CURRENT ONCOLOGY
-
Derginin Tarandığı İndeksler:
Academic Search Ultimate (EBSCO), Biomedical Reference Collection: Corporate Edition (EBSCO), Scopus, Science Citation Index Expanded (SCI-EXPANDED), CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals
-
Sayfa Sayıları:
ss.1-12
-
Kütahya Sağlık Bilimleri Üniversitesi Adresli:
Evet
Özet
Bone and brain metastases are rare in colorectal cancer, and prior studies have treated metastasis as a fixed baseline characteristic. We conducted a multicenter retrospective study of patients with colorectal cancer and bone and/or brain metastases at Turkish Oncology Group centers (May 2011 to September 2025). In multivariable Cox models, the opposite rare-site metastasis and post-metastasis targeted therapy were modeled as time-dependent covariates. Among 188 patients, 139 (73.9%) had bone-first, 33 (17.6%) brain-first, and 16 (8.5%) synchronous disease. Median overall survival was 13.6 months (95% CI 11.6 to 16.4), with no difference by phenotype (p = 0.705). Opposite-site involvement was associated with higher mortality in the bone-metastasis (aHR 2.149, p = 0.006) and brain-metastasis (aHR 2.076, p = 0.018) cohorts, reflecting brain metastasis developing during follow-up in the former and bone metastasis present at diagnosis in the latter. Carcinoembryonic antigen and neutrophil-to-lymphocyte ratio were independently prognostic (both p < 0.01). Anti-EGFR (aHR 0.356, p = 0.001) and anti-VEGF therapy (aHR 0.471, p = 0.005) were associated with lower mortality in patients with bone metastasis but not in those with brain metastasis. Brain metastasis developing in patients with bone metastases carries independent prognostic weight, while targeted-therapy associations in brain metastasis remain inconclusive.